Improving Survival and Cure Rates in Resectable NSCLC With Perioperative Immunotherapy
Co-Chairs, Nasser Altorki, MD, and Jonathan D. Spicer, MD, PhD, FRCSC, discuss NSCLC in this CME/MOC activity titled “Extending Survival and Setting Our Sights on Cure in Resectable NSCLC: Getting the Details of Perioperative Immunotherapy Right.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/CDB865. CME/MOC credit will be available until October 29, 2023.
